Standard & Poor's
S&P's Special Reports: India: Back In Investment Grade After 16 Years
Keywords: financial, trends, profile, risk, industry, statistics, market, outlook


Full Report Price: $500.00
Delivery: Immediate Online Access
Publication Date: 07-MAR-07
Pages: 27
Format: PDF document  PDF Electronic Document
Add to Cart image


Report Description

In This Issue:

India: Back In Investment Grade After 16 Years: On Jan. 30, 2007, Standard & Poor's raised its sovereign credit ratings on the Republic of India to 'BBB-/A-3'. The upgrade to investment grade reflects the country's strong economic prospects and external balance sheet, and its deep capital market, which supports a weak, but improving, fiscal position.

Opportunity Knocks For India's Banks As Strong Growth Continues: India's economic prospects remain stable and strong, with GDP growth likely to average more than 7.5% in the medium term. Economic growth is also benefiting from higher consumption and private investment demand, owing to a growing middle class and favorable demographics. As a result, Indian banks will have abundant opportunities for profitable growth, with minimal downward pressure on pricing or asset quality.

India's Global M&A Ambitions May Weaken Credit Risk Profiles: India's corporate landscape could see a year of record M&A deals in 2007, with companies actively considering nonorganic growth options. The number of M&As surged over the past three years, rising 26% in 2006 to 349 (from 276 in 2005), valued at US$11.9 billion. The rising tide of M&As has yet to affect credit risk profiles of Indian corporates significantly.

India Top 100 Corporates Overview: Satisfactory Financial Profile Expected To Continue: Operating in an environment of strong economic growth for the past four years, the Indian corporate sector has demonstrated a trend of consistent double-digit revenue growth. The trend is evident across a broad spectrum of industrial sectors, notably software and IT services and automotive sectors. In 2006 alone, foreign direct investment flowing into India increased by 43.9% to US$9.5 billion.

Indian Pharmaceutical Industry: Generics In The Pink Of Health: India's pharmaceutical industry ranks fourth in the world in volume and 13th in value terms. Keeping the sector healthy is the dominance of branded generic medicines-the proportion of innovative drugs that are still under patent is low. The size of the industry is about US$5.6 billion (INR250 billion), which is expected to grow 8% to 10% annually.



 

S&P Information Products

Browse S&P industry research products by category:

S&P Industry Surveys
S&P Industry Stock Reports
The Outlook
Search Engine Survey
Pocket Guides
Power Picks

About Standard & Poor's

Standard & Poor's is one of the world's preeminent providers of credit ratings, and for such globally recognized financial-market indices as the S&P 500®. S&P also provides a wide range of other products and services designed to help individuals and institutions around the world make better-informed financial decisions with greater confidence.

Home  Browse  Search  E-mail  Content Map
Standard & Poor's, 55 Water St., New York NY
Tel: 212-438-2000    Fax: 212-438-2000